Skip to main content
. 2019 Jun 11;20:350. doi: 10.1186/s13063-019-3362-z

Fig. 2.

Fig. 2

Study visit schedule. BSAP body surface area percentage, CCC confirmation of complete closure of the EB target wound, D day, EBDASI Epidermolysis Bullosa Disease Activity and Scarring Index, EDBP end of double-blind phase, FLACC Face, Legs, Activity, Cry, Consolability scale, TSQM Treatment Satisfaction Questionnaire for Medication; V visit, W-QoL Wound-Quality of Life Questionnaire